A new study in The Lancet shows the HPV vaccine has reduced cervical cancer deaths in the UK for women under 30 to effectively zero. Routine vaccinations began in 2008, and researchers found no deaths in the 20-24 age group between 2020-2024, compared to 23 expected without the vaccine.
New research shows HPV vaccination for 12-13 year olds has nearly eliminated cervical cancer deaths before age 30, saving around 200 lives in England. Vaccination rates are below WHO targets, prompting calls for urgent action.
Landmark research shows young women vaccinated against HPV at age 12-13 have near-zero risk of cervical cancer death before 30. Over 200 lives saved in England since 2008, with no deaths recorded in 20-24 age group recently. Experts urge high vaccination rates to meet elimination goals.
A study found HPV vaccination virtually eliminates cervical cancer deaths before age 30. However, falling vaccination rates in England could lead to hundreds of avoidable deaths annually, reversing progress towards elimination.
For the first time, Australia has recorded no new cervical cancer diganoses in women under 25.
Australia is on track to become the first country to eliminate cervical cancer by 2035, driven by its pioneering HPV vaccination program and advanced screening. The milestone carries profound personal meaning for women like Chrissy Walters, diagnosed with terminal cervical cancer shortly after giving birth, whose 12-year-old daughter is now reaching the age when Australia vaccinates children against the disease. The country has seen incidence and mortality rates halve since 1982, with no cases in women under 25 recorded in 2021 for the first time.
